Stockreport

Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating [Yahoo! Finance]

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
PDF Viking Therapeutics, Inc. (NASDAQ: VKTX ) ranks among the . On November 20, H.C. Wainwright retained its Buy rating and $102 price target for Viking Therapeutics, Inc. ( [Read more]